Skip to content

Medical emergency? What to do

Drug effective in smoking cessation studies

3-RXPublished November 16, 20052 min read

Key points

  • An experimental smoking cessation drug by Pfizer Inc. was more effective than GlaxoSmithKline Plc's rival medication in important late-stage studies, although the contrast was far less pronounced in the follow-up period, researchers said on Tuesday.
  • But the effect of the Pfizer drug was far less pronounced during a 40-week observation period following the studies of about 2,000 smokers.
  • In a second study, varenicline did only slightly better, 23 percent to 15 percent for Zyban.
  • "Varenicline is a leap forward for smokers and if it is approved it will be part of my doctor's bag," said Dr.

An experimental smoking cessation drug by Pfizer Inc. was more effective than GlaxoSmithKline Plc's rival medication in important late-stage studies, although the contrast was far less pronounced in the follow-up period, researchers said on Tuesday.

The 12-week studies, which Pfizer is expected to use to seek approval of the drug, showed 44 percent of smokers using Pfizer's varenicline were able to quit. That compared with 30 percent among those using Glaxo's Zyban, also known by the chemical name bupropion, and just 17.7 percent in the placebo group, according to data presented at the American Heart Association annual scientific sessions.

But the effect of the Pfizer drug was far less pronounced during a 40-week observation period following the studies of about 2,000 smokers.

During the ninth through 52nd week, researchers measuring continuous abstinence found a 22.1 percent rate for varenicline, compared with 16.4 percent for Zyban, a difference not considered statistically significant.

In a second study, varenicline did only slightly better, 23 percent to 15 percent for Zyban. Both drugs were much better than placebo in both studies.

A single puff of a cigarette counted as a return to smoking in the studies.

"Varenicline is a leap forward for smokers and if it is approved it will be part of my doctor's bag," said Dr. Serena Tonstad, a professor of nutrition at the University of Oslo who led the Pfizer-sponsored trial.

She said the drug is an attractive alternative to Zyban, which some patients cannot take because of allergic reactions and rare seizures linked to it.

Tonstad said people who successfully stayed off cigarettes well after the Pfizer treatment ended were able to do so largely with support from clinicians.

Varenicline works by partially stimulating and binding to the receptors in the brain that channel the rewarding, habit-forming properties of nicotine, researchers said.

Tonstad said there was no sign that the drug continues to exert a chemical effect on the brain very long after the patient stops taking it.

Pfizer shares were down 29 cents, or 1.3 percent, at $21.96 in morning New York Stock Exchange trade, where Glaxo fell less than 1 percent to $52.66.

On average, men who smoke die 13.2 years younger than nonsmokers, according to a 2004 report by the U.S. Surgeon General, while female smokers die 14.5 years younger than nonsmokers.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.